- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
International Journal of Polymer Science
Volume 2012 (2012), Article ID 216137, 12 pages
MonoMax Suture: A New Long-Term Absorbable Monofilament Suture Made from Poly-4-Hydroxybutyrate
1Aesculap AG, Am Aesculap-Platz, 78532 Tuttlingen, Germany
2B. Braun Surgical S.A., Carretera de Terrassa 121, 08191 Rubi, Spain
3Tepha Inc., 99 Hayden Avenue, Lexington, MA 02421, USA
Received 6 December 2011; Accepted 21 February 2012
Academic Editor: Kibret Mequanint
Copyright © 2012 Erich K. Odermatt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- M. K. Hirko, P. H. Lin, H. P. Greisler, and C. C. Chu, “Biological properties of suture materials,” in Wound Closure Materials, C. C. Chu, J. A. Von Fraunhofer, and H. P. Greisler, Eds., pp. 237–287, CRC Press, Boca Raton, Fla, USA, 1996.
- D. P. Martin and S. F. Williams, “Medical applications of poly-4-hydroxybutyrate: A strong flexible absorbable biomaterial,” Biochemical Engineering Journal, vol. 16, no. 2, pp. 97–105, 2003.
- Y. Doi, Microbial Polyesters, VCH, New York, NY, USA, 1990.
- S. F. Williams and D. P. Martin, “Applications of PHAs in Medicine and Pharmacy,” in Biopolymers, Y. Doi and A. Steinbüchel, Eds., pp. 91–127, Wiley-VCH, 2002.
- Q. Wu, Y. Wang, and G. Q. Chen, “Medical application of microbial biopolyesters polyhydroxyalkanoates,” Artificial Cells, Blood Substitutes, and Biotechnology, vol. 37, no. 1, pp. 1–12, 2009.
- G. W. Huisman, F. Skraly, D. P. Martin, and O. P. Peoples, “Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids,” US Patent no. 6,316,262.
- D. E. Dennis and H. E. Valentin, “Methods of making polyhydroxyalkanoates comprising 4-hydroxybutyrate monomer units,” US Patent no. 6,117,658.
- Y. Hori, A. Yamaguchi, and T. Hagiwara, “Chemical synthesis of high molecular weight poly(3-hydroxybutyrate-co-4-hydroxybutyrate),” Polymer, vol. 36, no. 24, pp. 4703–4705, 1995.
- K. N. Houk, A. Jabbari, H. K. Hall, and C. Alemán, “Why δ-valerolactone polymerizes and γ-butyrolactone does not,” Journal of Organic Chemistry, vol. 73, no. 7, pp. 2674–2678, 2008.
- “Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals,” ISO 10993-7:2008.
- The United States Pharmacopeia, The National Formulation USP 32-NF 27 (2010), chapter 881 Tensile Strength: 380, United States Pharmacopeial Convention INC. Rockville, Md, USA.
- European Pharmacopeia, The European Directorate for the Quality of Medicines & HealthCare, Strasbourg, France, 6th edition, 2010.
- H. Tera and C. Aberg, “Tensile strengths of twelve types of knot employed in surgery, using different suture materials,” Acta Chirurgica Scandinavica, vol. 142, no. 1, pp. 1–7, 1976.
- “Biological evaluation of medical devices - Part 1: Evaluation and testing,” ISO 10993-1:2003.
- R. S. Bezwada, D. D. Jamiolkowski, I. Y. Lee et al., “Monocryl suture, a new ultra-pliable absorbable monofilament suture,” Biomaterials, vol. 16, no. 15, pp. 1141–1148, 1995.
- G. T. Rodeheaver, K. A. Beltran, C. W. Green et al., “Biomechanical and clinical performance of a new synthetic monofilament absorbable suture,” Journal of Long-Term Effects of Medical Implants, vol. 6, no. 3-4, pp. 181–198, 1996.
- T. Nelson, E. Kaufman, J. Kline, and L. Sokoloff, “The extraneural distribution of γ-hydroxybutyrate,” Journal of Neurochemistry, vol. 37, no. 5, pp. 1345–1348, 1981.
- S. L. Sendelbeck and C. L. Girdis, “Disposition of a 14C-labeled bioerodible polyorthoester and its hydrolysis products, 4-hydroxybutyrate and cis,trans-1,4-bis(hydroxymethyl)cyclohexane, in rats,” Drug Metabolism and Disposition, vol. 13, no. 3, pp. 291–295, 1985.
- National Toxicology Program (NTP), “NTP Summary report on the metabolism, disposition and toxicity of 1,4-butanediol,” Toxicity Report 54, NIH Publication no. 96-3932, 1996.
- National Toxicology Program (NTP), “Toxicology and carcinogenesis studies of gamma-butyrolactone (CAS No. 96-48-0) in F344/N rats and B6C3F1 mice (gavage studies),” Technical Report 406, NIH Publication no. 92-3137, 1992.
- L. Fischer, P. Baumann, J. Hüsing et al., “A historically controlled, single-arm, multi-centre, prospective trial to evaluate the safety and efficacy of MonoMax suture material for abdominal wall closure after primary midline laparotomy. ISSAAC-Trial [NCT005725079],” BMC Surgery, vol. 8, article 12, 2008.
- M. Albertsmeier, C. M. Seiler, L. Fischer et al., “Evaluation of the safety and efficacy of MonoMax suture material for abdominal wall closure after primary midline laparotomy—a controlled prospective multicenter trial: ISSAAC [NCT005725079],” Langenbeck's Archives of Surgery, vol. 397, pp. 363–371, 2012.